Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (451-460 of 959) with videos related to

Pageof 96
Sort By:
Annals of the Rheumatic Diseases|November 27, 2012
Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management eraDavid Launay, Olivier Sitbon, Eric Hachulla, et al.
Pulmonary Circulation|April 19, 2021
Hypoxemia during sleep and overnight rostral fluid shift in pulmonary arterial hypertension: a pilot studyEtienne-Marie Jutant, David Montani, Caroline Sattler, et al.
Expert Opinion on Pharmacotherapy|August 21, 2015
New pharmacotherapy options for pulmonary arterial hypertensionSwanny Perrin, Marie-Camille Chaumais, Caroline O'Connell, et al.
Plos One|June 7, 2013
Temporal asthma patterns using repeated questionnaires over 13 years in a large French cohort of womenMargaux Sanchez, Jean Bousquet, Nicole Le Moual, et al.
American Journal of Respiratory and Critical Care Medicine|June 12, 2025
Detection and Evaluation of Drug-associated Pulmonary Arterial HypertensionClément Jambon-Barbara, Alex Hlavaty, Julien Grynblat, et al.
Chest|May 12, 2009
Is pulmonary arterial hypertension really a late complication of systemic sclerosis?Eric Hachulla, David Launay, Luc Mouthon, et al.
Therapeutic Advances in Respiratory Disease|April 15, 2014
The potential for macitentan, a new dual endothelin receptor antagonist, in the treatment of pulmonary arterial hypertensionAlexandru Steriade, Andrei Seferian, Xavier Jaïs, et al.
Drug Safety|January 11, 2016
Comparative Safety and Tolerability of Prostacyclins in Pulmonary HypertensionCaroline O'Connell, David Amar, Athénaïs Boucly, et al.
The European Respiratory Journal|May 20, 2022
Erythrocytes are altered in pulmonary arterial hypertensionEtienne-Marie Jutant, Ly Tu, Raphaël Thuillet, et al.
Respiratory Medicine|June 21, 2019
Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibilityMarc Humbert, Frank C Albers, Daniel J Bratton, et al.
Pageof 96

Showing results (451-460 of 959) with videos related to

Sort By:
Pageof 96
Annals of the Rheumatic Diseases|November 27, 2012
Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management eraDavid Launay, Olivier Sitbon, Eric Hachulla, et al.
Pulmonary Circulation|April 19, 2021
Hypoxemia during sleep and overnight rostral fluid shift in pulmonary arterial hypertension: a pilot studyEtienne-Marie Jutant, David Montani, Caroline Sattler, et al.
Expert Opinion on Pharmacotherapy|August 21, 2015
New pharmacotherapy options for pulmonary arterial hypertensionSwanny Perrin, Marie-Camille Chaumais, Caroline O'Connell, et al.
Plos One|June 7, 2013
Temporal asthma patterns using repeated questionnaires over 13 years in a large French cohort of womenMargaux Sanchez, Jean Bousquet, Nicole Le Moual, et al.
American Journal of Respiratory and Critical Care Medicine|June 12, 2025
Detection and Evaluation of Drug-associated Pulmonary Arterial HypertensionClément Jambon-Barbara, Alex Hlavaty, Julien Grynblat, et al.
Chest|May 12, 2009
Is pulmonary arterial hypertension really a late complication of systemic sclerosis?Eric Hachulla, David Launay, Luc Mouthon, et al.
Therapeutic Advances in Respiratory Disease|April 15, 2014
The potential for macitentan, a new dual endothelin receptor antagonist, in the treatment of pulmonary arterial hypertensionAlexandru Steriade, Andrei Seferian, Xavier Jaïs, et al.
Drug Safety|January 11, 2016
Comparative Safety and Tolerability of Prostacyclins in Pulmonary HypertensionCaroline O'Connell, David Amar, Athénaïs Boucly, et al.
The European Respiratory Journal|May 20, 2022
Erythrocytes are altered in pulmonary arterial hypertensionEtienne-Marie Jutant, Ly Tu, Raphaël Thuillet, et al.
Respiratory Medicine|June 21, 2019
Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibilityMarc Humbert, Frank C Albers, Daniel J Bratton, et al.
Pageof 96